Andreas W Schirmer

Title: Innovations of Andreas W. Schirmer in Biotechnology

Introduction

Andreas W. Schirmer is a prominent innovator and inventor based in South San Francisco, CA, with an impressive portfolio of 36 patents. His work primarily focuses on the fields of specialty chemicals and biotechnology, particularly concerning the production of fatty acids through bacterial synthesis.

Latest Patents

Among Schirmer's latest patents is the method for the production of non-native monounsaturated fatty acids in bacteria. This significant disclosure provides viable bacterial cells featuring heterologous dual 3-hydroxy-acyl-ACP dehydratase/isomerases. Importantly, the invention encompasses the methods for preparing and producing various non-native monounsaturated fatty acid derivative molecules, covering a range of omega derivatives such as ω3, ω5, ω9, and ω11-monounsaturated fatty acid derivatives. Another noteworthy patent pertains to omega-hydroxylase-related fusion polypeptide variants, which improve the production of omega-hydroxylated fatty acid derivatives when expressed in recombinant host cells. This disclosure facilitates the utilization of microorganisms for expressing the fusion polypeptides, further enhancing fatty acid derivative production.

Career Highlights

Schirmer's career includes significant contributions to organizations such as Genomatica, Inc. and Reg Life Sciences, LLC. His work in these companies has been pivotal in advancing biotechnological solutions and innovations that address modern challenges in specialty chemical production.

Collaborations

Throughout his career, Schirmer has collaborated with notable individuals in the field, including Mathew A. Rude and Shane A. Brubaker. Together, they have worked on groundbreaking projects that have pushed the boundaries of biotechnology and its applications in industrial settings.

Conclusion

Andreas W. Schirmer continues to be a leading figure in the biotech industry, consistently driving innovation through his patents and collaborative efforts. His contributions not only enhance our understanding of fatty acid synthesis in bacteria but also pave the way for sustainable practices in specialty chemical production.